Camille Perroud, Naomi Porret, Alicia Rovó
The differential diagnosis of erythrocytosis is complex, involving a tailored algorithm. Congenital causes are rare and such patients commonly face a long journey looking for diagnosis. This diagnosis requires expertise and accessibility to modern diagnostic tools. We present the case of a young Swiss man with long-standing erythrocytosis of unknown origin and his family. The patient had an episode of malaise as he went skiing above 2,000m altitude. In the blood gas analysis, the p50 was low (16 mmHg) and erythropoietin was normal...
March 20, 2023: Acta Haematologica
Maaya Awata-Shiraiwa, Akihiko Yokohama, Yukihiro Kanai, Nanami Gotoh, Tetsuhiro Kasamatsu, Hiroshi Handa, Takayuki Saitoh, Hirokazu Murakami, Junko Hirato, Hayato Ikota, Norifumi Tsukamoto
Introduction Waldenström macroglobulinemia (WM) represents a subset of lymphoplasmacytic lymphoma (LPL) with the immunoglobulin (Ig)M paraprotein. MYD88 L265P and CXCR4 mutations are common mutations in WM patients, and mutations in ARID1A and KMT2D (MLL2) have also been reported. However, little information has been accumulated on genetic changes in LPL with other paraproteins like IgG. Methods We therefore aimed to evaluate genetic differences between WM and LPL with non-IgM paraprotein (non-IgM-type LPL) using targeted next-generation sequencing (NGS) in 20 Japanese patients (10 with WM, 10 with non-IgM-type LPL)...
March 14, 2023: Acta Haematologica
Mingling Sun, Xiujuan Wang, Lei Wang, Xinyou Wang, Wenxia Fan, Ying Liu, Qinzhi Li, Ning Zhang, Xinhong Guo
Introduction Immune thrombocytopenia (ITP) is an autoimmune disease characterized by thrombocytopenia. Herein, we sought to identify potential immune-related therapeutic targets in ITP. Methods The differentially expressed genes (DEGs) between ITP patients and controls in GSE43177 and PRJNA299534 were analyzed. The intersections of the two DEG groups were screened as common genes, and enrichment analysis was performed. Additionally, differential analysis of immune cell levels between ITP and controls was performed...
March 14, 2023: Acta Haematologica
Giulia Milano, Laura Banov, Johanna Svahn, Marco Gucciardo, Fernando Marotta, Angelo Claudio Molinari
Successful management of surgery in severe coagulation disorders depends on adequate replacement of the deficient factors from intervention until wound healing. Extended half-life (EHL) recombinant factor IX (rFIX) has been increasingly used in hemophilia B (HB) patients. Monitoring of blood levels of EHL rFIX allows to obtain pharmacokinetic (PK) parameters in order to optimize and personalize therapeutic scheme. We describe a case of a young male with severe HB who successfully underwent aortic valve re-pair...
March 10, 2023: Acta Haematologica
Vasiliki Papadopoulou, Jacqueline Schoumans, Ilaria Scarpelli, Sabine Blum
The gene encoding for transcription factor ETV6 presents recurrent lesions in hematologic neoplasms, most notably the ETV6-RUNX1 rearrangement in childhood B-ALL. The role of ETV6 for normal hematopoiesis is unknown, but loss of its function probably participates in oncogenic procedures. In myeloid neoplasms, ETV6-locus (12p13) deletions are rare but recurrent; ETV6 translocations are even rarer, but those reported seem to have phenotype-defining consequences. We herein describe the genetic and hematologic profile of myeloid neoplasms with ETV6 deletions (10 cases), or translocations (4 cases) diagnosed in the last ten years in our institution...
February 27, 2023: Acta Haematologica
Mei Bao, Mengyu Zhang, Hongxia Shi, Xiaoli Liu, Minghui Duan, Junling Zhuang, Xin Du, Ling Qin, Wuhan Hui, Rong Liang, Meifang Wang, Ye Chen, Dongyun Li, Wei Yang, Gusheng Tang, Weihua Zhang, Xia Kuang, Wei Su, Yanqiu Han, Limei Chen, Jihong Xu, Zhuogang Liu, Jian Huang, Chunting Zhao, Hongyan Tong, Jianda Hu, Chunyan Chen, Xiequn Chen, Zhijian Xiao, Qian Jiang
Introduction Genetic landscape, disease characteristics and clinical outcomes of young adults with myeloproliferative neoplasms (MPNs) were reported. However, data on patient-reported outcomes (PROs) in young adults with MPNs were rare. Methods We conducted a multicenter, cross-sectional study to compared the PROs in respondents with thrombocythemia (ET), polycythemia vera (PV) and myelofibrosis (MF) by age at survey, including the young group (18-40 years), middle-aged group (41-60 years), and elderly group (> 60 years)...
February 22, 2023: Acta Haematologica
Michael Iarossi, Cédric Hermans
Acquired von Willebrand syndrome is a rare entity with approximately 700 cases described in the literature. Many etiologies are responsible for this condition, mainly lymphoproliferative and myeloproliferative syndromes, as well as cardiac diseases. Several mechanisms have been involved depending on the etiology. Viral infections are an extremely rare cause, with one case reported after an EBV infection. In this case report we describe the very likely association between SARS-CoV2 infection and the development of a time-limited acquired von Willebrand syndrome...
February 20, 2023: Acta Haematologica
Farida Almarzooqi, Hilary Vallance, Michelle M Mezei, Anna Lehman, Gabriella Horvath, Bojana Rakic, Leslie Zypchen, Andre Mattman
Large single mtDNA (mitochondrial DNA) deletion syndrome is a rare inborn error of metabolism with variable heteroplasmy levels and clinical phenotype among affected individuals. Chronic progressive external ophthalmoplegia (CPEO) is the most common phenotype in adults with this form of mitochondrial disease [1-2]. The common CPEO clinical manifestations are ptosis and ophthalmoplegia. More variable phenotypic manifestations of CPEO (CPEO plus) include involvement of the peripheral nervous system and myopathy...
February 10, 2023: Acta Haematologica
Xiaoye Sun, Yifeng Cai, Hui Ni, Hui Cong
INTRODUCTION: In clinical diagnosis and treatment, we found that PLT counts failed to increase significantly or even decreased progressively in some patients after receiving PLT transfusion. OBJECTIVE: The aim of this study was to observe the therapeutic effect of platelet (PLT) transfusion and analyze influencing factors for the sake. METHODS: Included in this study were patients who received PLT transfusion in our hospital. Patients' sex, age, height, weight, PLT transfusion status, and 20-24-h PLT count before and after PLT transfusion were collected to calculate the PLT corrected count increment (CCI) values before and after PLT transfusion...
February 9, 2023: Acta Haematologica
Nitya Prabhakaran, George Jour, Arjun Balar, Nicholas Ward
Erdheim-Chester disease (ECD) is a rare clonal histiocytic process that is characterized by a foamy (xanthomatous) proliferation often associated with Touton giant cells. The diagnosis is often challenging and not exclusively a histologic diagnosis, as it requires correlation with unique clinical, radiographic and recently described molecular findings. Activating mutations involving the MAPK pathway including BRAF, ARAF, N/KRAS and MEK are recurrent in the disease. However, it is increasingly being described that mutations associated with clonal hematopoiesis are also found in bone marrow specimens of patients with Erdheim-Chester disease (ECD), as well as higher frequency of overt concomitant myeloid malignancy including acute myeloid leukemia, myeloproliferative neoplasms, myelodysplastic syndromes, and mixed myeloproliferative neoplasms/myelodysplastic syndromes...
February 8, 2023: Acta Haematologica
Haihui Zhuang, Fenglin Li, Ting Si, Pei Renzhi, Mengxia Yu, Dong Chen, Peipei Ye, Ying Lu
INTRODUCTION: Recent studies have suggested that CD300A was an oncogene in acute myeloid leukemia (AML) development. However, the clinical relevance and biological insight into CD300A expression in AML are still not well understood. The present study aimed to examine the expression characteristics of CD300A in AML and confirmed its clinical significance for AML. METHODS: Quantification of the CD300A transcript was performed in 119 AML patients by real-time quantitative PCR in bone marrow blasts...
February 6, 2023: Acta Haematologica
Idan Goldberg, Eytan Cohen, Anat Gafter-Gvili, Tzippy Shochat, Eitan Kugler, Ili Margalit, Elad Goldberg, Pia Raanani, Ilan Krause
INTRODUCTION: We aim to assess the natural annual trends in the levels of haemoglobin, haematocrit and mean corpuscular volume (MCV) in a population of adults, together with the influence of different clinical parameters on these trends. METHODS: A retrospective analysis was carried out on data from a large cohort of subjects attending a screening centre in Israel. For each subject, the yearly average change of haemoglobin, haematocrit and MCV was calculated. Statistical analysis was performed for the whole cohort and for different subgroups...
February 1, 2023: Acta Haematologica
Xiangmin Wang, Yi Zhou, Qian Sun, Hongyuan Zhou, Qing Zhang, Ziyuan Shen, Jie Huang, Yao Xue, Dongmei Yan, Yongjun Fang, Wei Sang
INTRODUCTION: Hemophagocytic lymphohistiocytosis (HLH) is a rare immune disorder with rapid progression and high mortality. There have been few large cohort studies comparision of pediatric and adult HLH until now. This study was designed to explore the disparity of clinical presentations and evaluate the prognosis in pediatric and adult HLH patients. METHODS: Totally 525 newly diagnosed HLH patients were included and divided into 4 groups according to age: <6, 6-18, 18-60 and>60 years (geriatric patients)...
January 9, 2023: Acta Haematologica
Charles Guisnel, Luciane Schirmer, Stéphane Morisset, Marie Robin, Hélène Labussière-Wallet, Rémy Duléry, Patrice Ceballos, Edouard Forcade, Stéphanie Nguyen, Xavier Poiré, Johan Maertens, Sylvain Chantepie, Patrice Chevallier, Etienne Daguindau, Alban Villate, Amandine Charbonnier, Cristina Castilla-Llorente, Nathalie Contentin, Anne Huynh, Ibrahim Yakoub-Agha, Claude Eric Bulabois, Marie-Thérèse Rubio, Maud D'Aveni
INTRODUCTION: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains the best curative option for high-risk myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). Unfortunately, it is still associated with a significant risk of relapse due to mechanisms of escape from the control of alloreactive T cells. Repetitive adjuvant donor lymphocyte infusions (DLI), termed prophylactic DLI (proDLI), as an effective strategy in preventing relapse is still debated. METHODS: We performed a retrospective multicenter study to evaluate the efficacy of proDLI in allografted AML and MDS...
January 5, 2023: Acta Haematologica
Shengchen Ge, Yuqing Luo, Rujiao Dong, Xiaoli Guo, Mingshan Wang, Yi Chen
The objective of this study was to explore the molecular defects in two Chinese families with hypodysfibrinogenemia. The coagulation method and immunoturbidimetric method were used to detect plasma fibrinogen activity and plasma fibrinogen antigen. The fibrinogen genes were amplified by PCR and suspected mutations were confirmed by reverse sequencing. Bioinformatics and model analysis were used to study the conservatism and harm of the mutations. Study showed that the Fg:C and Fg:Ag of the probands of the two families were reduced respectively to 0...
January 4, 2023: Acta Haematologica
Yin Liu, Han-Xi Zhang, Juan Su, Qing-Chao Geng, Xin Lin, Chen-Xi Feng
INTRODUCTION: To conduct a network meta-analysis to assess the efficacy and incidence of treatment related adverse events (TRAEs) of eltrombopag, romiplostim, avatrombopag, recombinant human thrombopoietin (rhTPO) and hetrombopag for adult immune thrombocytopenia (ITP). METHODS: Randomized controlled trails (RCTs) of the five therapies from inception to June 1, 2022 were included. The efficacy outcome was the rate of platelet response, defined as the achievement of platelet counts above 50 x 109/L...
December 26, 2022: Acta Haematologica
Shuting Jiang, Yuan Chen, Meina Liu, Manlin Zeng, Lihong Yang, Yanhui Jin, Kaiqi Jia, Mingshan Wang
INTRODUCTION: Mutations in the F11 gene can cause factor Ⅺ (FⅪ) deficiency, leading to abnormal coagulation activity and injury-related bleeding tendency. Therefore, identifying F11 gene mutations and studying the molecular basis will help us understand the pathogenesis of FⅪ deficiency. METHODS: Coagulation tests and gene sequencing analysis of all members were performed. FⅪ wild-type and mutant expression plasmids were constructed and transfected into HEK293FT cells...
December 21, 2022: Acta Haematologica
Mansour Masjedi, Sina Azadikhah, Farid Zand, Naeimehossadat Asmarian, Golnar Sabetian, Mina Ostovan, Vida Naderi-Boldaji
BACKGROUND: Management of anticoagulant therapy in COVID-19 patients is a critical role. Low Molecular Weight Heparin (LMWH) thromboprophylaxis is already recommended and anti-Factor Xa (anti-FXa) monitoring has been used to titrate LMWH doses. METHODS: Through a cross-sectional study, we evaluated anti-FXa activity in patients admitted to ICU, receiving intermediate dose (30, 40, 50mg, subcutaneously (SC), twice daily) or therapeutic dose (1 mg/kg, SC, Q12h) of enoxaparin to find whether the patients of these two groups achieve anti-FXa levels in the accepted thromboprophylaxis range...
December 20, 2022: Acta Haematologica
Carlos Andres Regino Agamez, Jose Domingo Torres, Camilo Caceres-Galvis, Huxlhey Braulio Cabrera, Miguel A Sanz
The association of glomerulonephritis and malignant hematological disease is uncommon, but well known in chronic leukemias, lymphomas, and monoclonal gammopathies. However, only a few cases of glomerulonephritis and acute myeloid leukemia has been reported in the literature. We describe the first case of a genetically diagnosed acute promyelocytic leukemia presenting with nephrotic range proteinuria that resolved with induction therapy with ATRA and ATO and performed a comprehensive review of the literature...
December 20, 2022: Acta Haematologica
Amber Chen-Goodspeed, Goutham Dronavalli, Xu Zhang, Jeanette Podbielski, Bela Patel, Katalin Modis, Bryan Cotton, Charles Wade, Jessica C Cardenas
BACKGROUND: Severe COVID-19 illness can lead to thrombotic complications, organ failure, and death. Antithrombin (AT) regulates thromboinflammation and is a key component of chemical thromboprophylaxis. Our goal was to examine the link between AT activity and responsiveness to thromboprophylaxis, markers of hypercoagulability, and inflammation among severe COVID-19 patients. METHODS: A single-center, prospective observational study enrolling SARS-CoV-2 positive patients admitted to the intensive care unit on prophylactic enoxaparin...
December 20, 2022: Acta Haematologica
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read

Save your favorite articles in one place with a free QxMD account.


Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.